Series B · Biotech
Pixelgen Technologies: Series B
High-throughput platform mapping molecular cell architecture at nanoscale resolution
Funding history
Series B · This round$15.5M
Loading rounds…
High-throughput platform mapping molecular cell architecture at nanoscale resolution